価格表

在庫・価格 : 2024年04月24日 12時57分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
MM MRD Kit
データシート※最新のデータシートでない場合があります
CYT-MM-MRD CGSサイトグノス
Cytognos, S. L.
1 kit この製品の取扱は終了しました

在庫・価格 : 2024年04月24日 12時57分 現在

MM MRD Kit

  • 商品コード:CYT-MM-MRD
  • メーカー:CGS
  • 包装:1kit
  • この製品の取扱は終了しました
使用文献
No. 文献情報 備考 参照
1 Stetler-Stevenson M et al. Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition. Cytometry B Clin Cytom 2016 Jan;90(1):26-30
Stetler-Stevenson M et al
2016/01/01
PubMed
2 Arroz M et al. Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting. Cytometry B Clin Cytom 2016 Jan;90(1):31-9
Arroz M et al
2016/01/01
PubMed
3 Paiva B et al. Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders. Cytometry B Clin Cytom 2010 Jul;78(4):239-52
Paiva B et al
2010/01/01
PubMed
4 Rawstron AC et al. Minimal residual disease assessed by multiparameter flow cytometry in multiple myeloma: impact on outcome in the Medical Research Council Myeloma IX Study. J Clin Oncol 2013 Jul;31(20):2540-7
Rawstron AC et al
2013/01/01
PubMed
5 Roschewski M et al. Minimal residual disease: what are the minimum requirements? J Clin Oncol 2014 Feb;32(5):475-6
Roschewski M et al
2014/01/01
PubMed
6 Rawstron AC et al. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica 2008 Mar;93(3):431-8
Rawstron AC et al
2008/01/01
PubMed
7 van Velzen JF et al. Inability of a monoclonal anti-light chain antibody to detect clonal plasma cells in a patient with multiple myeloma by multicolor flow cytometry. Cytometry B Clin Cytom ;84(1):30-2
van Velzen JF et al
PubMed
8 Kalina T et al. EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Leukemia 2012 Sep;26(9):1986-2010
Kalina T et al
2012/01/01
PubMed
9 Ocqueteau M et al. Expression of the CD117 antigen (c-Kit) on normal and myelomatous plasma cells. Br J Haematol 1996 Dec;95(3):489-93
Ocqueteau M et al
1996/01/01
PubMed
10 Flores-Montero J et al. Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma. Leukemia 2017 10;31(10):2094-2103
Flores-Montero J et al
2017/01/01
PubMed
  • No.: 1
  • 文献情報:
    Stetler-Stevenson M et al. Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition. Cytometry B Clin Cytom 2016 Jan;90(1):26-30
    Stetler-Stevenson M et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Arroz M et al. Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting. Cytometry B Clin Cytom 2016 Jan;90(1):31-9
    Arroz M et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Paiva B et al. Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders. Cytometry B Clin Cytom 2010 Jul;78(4):239-52
    Paiva B et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Rawstron AC et al. Minimal residual disease assessed by multiparameter flow cytometry in multiple myeloma: impact on outcome in the Medical Research Council Myeloma IX Study. J Clin Oncol 2013 Jul;31(20):2540-7
    Rawstron AC et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Roschewski M et al. Minimal residual disease: what are the minimum requirements? J Clin Oncol 2014 Feb;32(5):475-6
    Roschewski M et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Rawstron AC et al. Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders. Haematologica 2008 Mar;93(3):431-8
    Rawstron AC et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    van Velzen JF et al. Inability of a monoclonal anti-light chain antibody to detect clonal plasma cells in a patient with multiple myeloma by multicolor flow cytometry. Cytometry B Clin Cytom ;84(1):30-2
    van Velzen JF et al
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Kalina T et al. EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Leukemia 2012 Sep;26(9):1986-2010
    Kalina T et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Ocqueteau M et al. Expression of the CD117 antigen (c-Kit) on normal and myelomatous plasma cells. Br J Haematol 1996 Dec;95(3):489-93
    Ocqueteau M et al
    1996/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Flores-Montero J et al. Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma. Leukemia 2017 10;31(10):2094-2103
    Flores-Montero J et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed